Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients.

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc in the context of lupus (sle).

Curcumin-piperine might synergise with vitamin D to induce clinical remission in patients with systemic lupus erythematosus (SLE).

Who Took Part

By PubMed's age tags, the people studied were young adults, adults and middle-aged adults, women only.

Forty-five female SLE patients were included in a three-month double-blind, randomized controlled trial.

Mexican SLE disease activity score (Mex- SLEDAI), fatigue severity scale (FSS), TGF-β, and IL-6 levels were measured from all patients before and after the treatments.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.

Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

What Was Measured

The subject headings attached to it are Alkaloids, Benzodioxoles, Cholecalciferol, Curcumin, Cytokines, Lupus Erythematosus, Systemic and Piperidines.

The authors tagged it with the keywords Systemic lupus erythematosus, disease activity, inflammatory cytokines, piperine and vitamin D.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in people with lupus (sle).

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (Current rheumatology reviews), a journal based in United Arab Emirates.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, Lupus (SLE) research.